Matches in Wikidata for { <http://www.wikidata.org/entity/Q93581700> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q93581700 description "clinical trial" @default.
- Q93581700 description "ensayo clínico" @default.
- Q93581700 description "ensayu clínicu" @default.
- Q93581700 description "klinisch onderzoek" @default.
- Q93581700 description "клінічне випробування" @default.
- Q93581700 description "临床试验" @default.
- Q93581700 name "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 name "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 type Item @default.
- Q93581700 label "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 label "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 prefLabel "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 prefLabel "Abemaciclib With or Without T-DM1 for the Treatment of HER2-Positive Metastatic Breast Cancer" @default.
- Q93581700 P1050 Q93581700-82F8F5BF-65F6-47B8-B7FB-AE31F9E19F66 @default.
- Q93581700 P1132 Q93581700-EB95DD5E-226F-4EA2-A6CC-54B013DF7A06 @default.
- Q93581700 P1476 Q93581700-F85B3875-D06F-41B3-B2E8-E5840742FD35 @default.
- Q93581700 P17 Q93581700-DD54B64F-BB82-47EA-A0B7-B138E5658C82 @default.
- Q93581700 P2899 Q93581700-BE32E854-9B36-43C4-9C67-F57B93F207E0 @default.
- Q93581700 P3098 Q93581700-72EA637D-6CEB-4CF2-B245-1B0C28504FB0 @default.
- Q93581700 P31 Q93581700-FA27E5B7-2E05-4E1B-9822-B57C971956D9 @default.
- Q93581700 P4844 Q93581700-12CD58C2-D7C3-4F53-A016-F5BD6E6BEA20 @default.
- Q93581700 P4844 Q93581700-2FD284D7-58B5-4FBF-995B-4A0F1EB86A0E @default.
- Q93581700 P4844 Q93581700-C9C43E95-F2ED-4C7B-BF14-C9B446CD6D7E @default.
- Q93581700 P580 Q93581700-808DF7AB-4445-473B-92B8-5B94DAEBF042 @default.
- Q93581700 P582 Q93581700-6D9EBEA0-8D27-496E-BDFF-F3BD4273A45B @default.
- Q93581700 P6099 Q93581700-BE90C20F-7263-4F48-8427-505C1D83C27D @default.
- Q93581700 P767 Q93581700-EE4F3070-A93A-451D-AC2B-7BDD5CE053F3 @default.
- Q93581700 P8005 Q93581700-F726C6EF-DCED-49FD-B39E-27B0A0CE6B23 @default.
- Q93581700 P8363 Q93581700-3E76908B-08E6-477B-8D75-28FE19398CEB @default.
- Q93581700 P1050 Q33525 @default.
- Q93581700 P1132 "+126" @default.
- Q93581700 P1476 "Phase II Trial of T-DM1 +/- Abemaciclib, in Women and Men With HER2-Positive Advanced or Metastatic Breast Cancer Who Progressed on Treatment With a Taxane, Trastuzumab and Pertuzumab" @default.
- Q93581700 P17 Q30 @default.
- Q93581700 P2899 "+18" @default.
- Q93581700 P3098 "NCT04351230" @default.
- Q93581700 P31 Q30612 @default.
- Q93581700 P4844 Q3997863 @default.
- Q93581700 P4844 Q412616 @default.
- Q93581700 P4844 Q6720157 @default.
- Q93581700 P580 "2020-05-29T00:00:00Z" @default.
- Q93581700 P582 "2025-05-29T00:00:00Z" @default.
- Q93581700 P6099 Q42824440 @default.
- Q93581700 P767 Q664846 @default.
- Q93581700 P8005 Q76649614 @default.
- Q93581700 P8363 Q78089383 @default.